VitaNova Life Sciences Corporation Accounts Receivable, before Allowance for Credit Loss, Current
VitaNova Life Sciences Corporation (VNOV) had Accounts Receivable, before Allowance for Credit Loss, Current of $378.24 thousand as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableGrossCurrent · last filed 2026-09-14
- 2026-07-31: Accounts Receivable, before Allowance for Credit Loss, Current $378.24K.
- 2026-04-30: Accounts Receivable, before Allowance for Credit Loss, Current $788.11K.
- 2026-01-31: Accounts Receivable, before Allowance for Credit Loss, Current $1.00M.
- 2025-10-31: Accounts Receivable, before Allowance for Credit Loss, Current $882.61K.
| Period end | Accounts Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2026-07-31 | $378.24K 10-Q · filed 2026-09-14 |
| 2026-04-30 | $788.11K 10-Q · filed 2026-09-14 |
| 2026-01-31 | $1.00M 10-Q · filed 2026-03-16 |
| 2025-10-31 | $882.61K 10-Q · filed 2025-12-15 |
| 2025-07-31 | $1.01M 10-Q · filed 2025-09-12 |
| 2025-04-30 | $1.27M 10-K · filed 2026-07-29 |
| 2025-01-31 | $54.02K 10-Q · filed 2025-03-17 |
| 2024-10-31 | $57.70K 10-Q · filed 2024-12-13 |
| 2024-04-30 | $0.00 10-Q · filed 2025-03-17 |